173 related articles for article (PubMed ID: 35044727)
1. Home cage measures of Alzheimer's disease in the rTg4510 mouse model.
Barabas AJ; Robbins LA; Gaskill BN
Genes Brain Behav; 2022 Feb; 21(2):e12795. PubMed ID: 35044727
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration.
Holton CM; Hanley N; Shanks E; Oxley P; McCarthy A; Eastwood BJ; Murray TK; Nickerson A; Wafford KA
Alzheimers Res Ther; 2020 Jul; 12(1):84. PubMed ID: 32669112
[TBL] [Abstract][Full Text] [Related]
3. TAPPing into the potential of inducible tau/APP transgenic mice.
Xu G; Ulm BS; Howard J; Fromholt SE; Lu Q; Lee BB; Walker A; Borchelt DR; Lewis J
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12791. PubMed ID: 35067965
[TBL] [Abstract][Full Text] [Related]
4. Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy.
Blackmore T; Meftah S; Murray TK; Craig PJ; Blockeel A; Phillips K; Eastwood B; O'Neill MJ; Marston H; Ahmed Z; Gilmour G; Gastambide F
Alzheimers Res Ther; 2017 Sep; 9(1):77. PubMed ID: 28931441
[TBL] [Abstract][Full Text] [Related]
5. Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy.
Wang X; Smith K; Pearson M; Hughes A; Cosden ML; Marcus J; Hess JF; Savage MJ; Rosahl T; Smith SM; Schachter JB; Uslaner JM
PLoS One; 2018; 13(4):e0195486. PubMed ID: 29624602
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent impairment of memory and neurofibrillary tangle formation and clearance in a mouse model of tauopathy.
Kubota T; Kirino Y
Brain Res; 2021 Aug; 1765():147496. PubMed ID: 33894222
[TBL] [Abstract][Full Text] [Related]
7. Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology.
Song L; Lu SX; Ouyang X; Melchor J; Lee J; Terracina G; Wang X; Hyde L; Hess JF; Parker EM; Zhang L
Mol Neurodegener; 2015 Mar; 10():14. PubMed ID: 25881209
[TBL] [Abstract][Full Text] [Related]
8. Cornel Iridoid Glycoside Suppresses Hyperactivity Phenotype in rTg4510 Mice through Reducing Tau Pathology and Improving Synaptic Dysfunction.
Ma DL; Luo Y; Huang R; Zhao ZR; Zhang L; Li YL; Wang Q; Li L; Zhang L
Curr Med Sci; 2020 Dec; 40(6):1031-1039. PubMed ID: 33428130
[TBL] [Abstract][Full Text] [Related]
9. Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model.
Jul P; Volbracht C; de Jong IE; Helboe L; Elvang AB; Pedersen JT
J Alzheimers Dis; 2016; 49(3):783-95. PubMed ID: 26519432
[TBL] [Abstract][Full Text] [Related]
10. Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model.
Bailey RM; Howard J; Knight J; Sahara N; Dickson DW; Lewis J
Mol Neurodegener; 2014 Jan; 9():8. PubMed ID: 24428919
[TBL] [Abstract][Full Text] [Related]
11. Study of tau pathology in male rTg4510 mice fed with a curcumin derivative Shiga-Y5.
Yanagisawa D; Hamezah HS; Durani LW; Taguchi H; Tooyama I
PLoS One; 2018; 13(12):e0208440. PubMed ID: 30521594
[TBL] [Abstract][Full Text] [Related]
12. Altered function of hippocampal CA1 pyramidal neurons in the rTg4510 mouse model of tauopathy.
Dalby NO; Volbracht C; Helboe L; Larsen PH; Jensen HS; Egebjerg J; Elvang AB
J Alzheimers Dis; 2014; 40(2):429-42. PubMed ID: 24448785
[TBL] [Abstract][Full Text] [Related]
13. Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice.
Gamache J; Benzow K; Forster C; Kemper L; Hlynialuk C; Furrow E; Ashe KH; Koob MD
Nat Commun; 2019 Jun; 10(1):2479. PubMed ID: 31171783
[TBL] [Abstract][Full Text] [Related]
14. Imaging the accumulation and suppression of tau pathology using multiparametric MRI.
Holmes HE; Colgan N; Ismail O; Ma D; Powell NM; O'Callaghan JM; Harrison IF; Johnson RA; Murray TK; Ahmed Z; Heggenes M; Fisher A; Cardoso MJ; Modat M; Walker-Samuel S; Fisher EM; Ourselin S; O'Neill MJ; Wells JA; Collins EC; Lythgoe MF
Neurobiol Aging; 2016 Mar; 39():184-94. PubMed ID: 26923415
[TBL] [Abstract][Full Text] [Related]
15. Increased Cerebral Level of P2X7R in a Tauopathy Mouse Model by PET Using [
Kong Y; Cao L; Wang J; Zhuang J; Liu Y; Bi L; Qiu Y; Hou Y; Huang Q; Xie F; Yang Y; Shi K; Rominger A; Guan Y; Jin H; Ni R
ACS Chem Neurosci; 2024 Jun; 15(11):2112-2120. PubMed ID: 38776461
[TBL] [Abstract][Full Text] [Related]
16. Differential accumulation of tau pathology between reciprocal F1 hybrids of rTg4510 mice.
Yanagisawa D; Hamezah HS; Pahrudin Arrozi A; Tooyama I
Sci Rep; 2021 May; 11(1):9623. PubMed ID: 33953293
[TBL] [Abstract][Full Text] [Related]
17. Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510).
Yang D; Xie Z; Stephenson D; Morton D; Hicks CD; Brown TM; Sriram R; O'Neill S; Raunig D; Bocan T
Neuroimage; 2011 Feb; 54(4):2652-8. PubMed ID: 21035554
[TBL] [Abstract][Full Text] [Related]
18. Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy.
Yue M; Hanna A; Wilson J; Roder H; Janus C
Neurobiol Aging; 2011 Apr; 32(4):590-603. PubMed ID: 19427061
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy.
Takaichi Y; Chambers JK; Inoue H; Ano Y; Takashima A; Nakayama H; Uchida K
Acta Neuropathol Commun; 2020 Jun; 8(1):86. PubMed ID: 32560668
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model.
Wang H; Li Y; Ryder JW; Hole JT; Ebert PJ; Airey DC; Qian HR; Logsdon B; Fisher A; Ahmed Z; Murray TK; Cavallini A; Bose S; Eastwood BJ; Collier DA; Dage JL; Miller BB; Merchant KM; O'Neill MJ; Demattos RB
Mol Neurodegener; 2018 Dec; 13(1):65. PubMed ID: 30558641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]